Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters

Journal of Affective Disorders

Volumn 124, Issue 1-2, 2010, Pages 134-140

  Stanley, Barbara ^a,b   Sher, Leo ^a,b   Wilson, Scott ^a,b   Ekman, Rolf ^c   Huang, Yung yu ^a   Mann, J John ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia University ^*  (United States)

^c Institute of Clinical Neuroscience   (Sweden)

Author keywords

Endogenous opioids; Monoamine metabolites; Non suicidal self injury

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BETA ENDORPHIN; DYNORPHIN; ENDORPHIN; HOMOVANILLIC ACID; METENKEPHALIN; MONOAMINE; NEUROTRANSMITTER;

ADULT; ANAMNESIS; ARTICLE; AUTOMUTILATION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOPELESSNESS; HUMAN; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; AGED; AROUSAL; BETA-ENDORPHIN; DYNORPHINS; ENKEPHALIN, METHIONINE; FEMALE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; PERSONALITY DISORDERS; REFERENCE VALUES; SELF-INJURIOUS BEHAVIOR; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 77952289482     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.10.028     Document Type: Article

References (93)

1. Akil H., Watson S.J., Young E., Lewis M.E., Khachaturian H., and Walker J.M. Endogenous opioids: biology and function. Annu. Rev. Neurosci. 7 (1984) 223-255
2. Allen S.M., and Rice S.N. Risperidone antagonism of self-mutilation in a Lesch-Nyhan patient. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 20 (1996) 793-800
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), Author, Washington, DC
4. Anderson L.T., and Ernst M. Self-injury in Lesch-Nyhan disease. J. Autism Dev. Disord. 24 (1994) 67-81
5. Baron M. The Schedule for Interviewing Borderlines (1980), New York State Psychiatric Institute, New York, NY
6. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 12 (1965) 63-70
7. Bramnert M., Ekman R., Larson I., and Thorell J.I. Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin. Regul. Pept. 5 (1982) 65-75
8. Bremner J.D. Long-term effects of childhood abuse on brain and neurobiology. Child Adolesc. Psychiatr. Clin. N. Am. 12 (2003) 271-292
9. Brewerton T.D., Lydiard R.B., Laraia M.T., Shook J.E., and Ballenger J.C. CSF β-endorphin and dynorphin in bulimia nervosa. Am. J. Psychiatry 149 (1992) 1086-1090
10. Buss A.H., and Durkee A. An inventory for assessing different kinds of hostility. J. Consult. Psychol. 21 (1957) 343-349
11. Bystritsky A., and Strausser B.P. Treatment of obsessive-compulsive cutting behavior with naltrexone. J. Clin. Psychiatry 57 (1996) 423-424
12. Carrasco J.L., Diaz-Marsa M., Pastrana J.I., Molina R., Brotons L., and Lopez-Ibor M.I. Hypothalamic-pituitary-adrenal axis response in borderline personality disorder without post-traumatic features. Br. J. Psychiatry 190 (2007) 357-358
13. Casner J.A., Weinheimer B., and Gualtieri C.T. Naltrexone and self-injurious behavior: a retrospective population study. J. Clin. Psychopharmacol. 16 (1996) 389-394
14. Chabane N., Leboyer M., and Mouren-Simeoni M.C. Opiate antagonists in children and adolescents. Eur. Child Adolesc. Psychiatry 9 (2000) I44-I50
15. Claes L., Vandereycken W., and Vertommen H. Pain experience related to self-injury in eating disorder patients. Eat. behav. 7 (2006) 204-213
16. Coid J., Allolio B., and Rees L.H. Raised plasma met-enkephalin in patients who habitually mutilate themselves. Lancet 2 (1983) 545-546
17. Crowell S.E., Beauchaine T.P., McCauley E., Smith C.J., Stevens A.L., and Sylvers P. Psychological, autonomic, and serotonergic correlates of parasuicide among adolescent girls. Dev. Psychopathol. 17 (2005) 1105-1127
18. De Riu P.L., Petruzzi V., Caria M.A., Mameli O., Casu A.R., Nuvoli S., Spanu A., and Madeddu G. β-endorphin and cortisol levels in plasma and CSF following acute experimental spinal traumas. Physiol. Behav. 62 (1997) 1-5
19. Demitrack M.A., Putnam F.W., Rubinow D.R., Pigott T.A., Altemus M., Krahn D.D., and Gold P.W. Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and β-endorphin in patients with eating disorders: a pilot study. Psychiatry Res. 49 (1993) 1-10
20. Fields H. State-dependent opioid control of pain. Nat. Rev. Neurosci. 5 (2004) 565-575
21. Garcia D., and Smith R.G. Using analog baselines to assess the effects of naltrexone on self-injurious behavior. Res. Dev. Disabil. 20 (1999) 1-21
22. Gardner D.L., Lucas P.B., and Cowdry R.W. CSF metabolites in borderline personality disorder compared with normal controls. Biol. Psychiatry 28 (1990) 247-254
23. Geracioti T.D., Nicholson W.E., Orth D.N., Ekhator N.N., and Loosen P.T. Cholecytokinin in human cerebrospinal fluid: concentrations, dynamics, molecular forms and relationship to fasting and feeding in health, depression and alcoholism. Brain Res. 629 (1993) 260-268
24. Gillberg C., Terenius L., Hagberg B., Witt-Engerström I., and Eriksson I. CSF β-endorphins in childhood neuropsychiatric disorders. Brain Dev. 12 (1990) 88-92
25. Good A.J., and Westbrook R.F. Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Behav. Neurosci. 109 (1995) 631-641
26. Gratz K.L. Risk factors for and functions of deliberate self-harm: an empirical and conceptual review. Clin. Psychol. Sci. Pract. 10 (2003) 192-225
27. Gross-Isseroff R., Dillon K.A., Israeli M., and Biegon A. Regionally selective increases in mu opioid receptor density in the brains of suicide victims. Brain Res. 530 (1990) 312-316
28. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
29. Hawton K., and Harriss L. Deliberate self-harm in people aged 60 years and over: characteristics and outcome of a 20-year cohort. Int. J. Geriatr. Psychiatry 21 (2006) 572-581
30. Hawton K., and Harriss L. Deliberate self-harm in young people: characteristics and subsequent mortality in a 20 year cohort of patients presenting to hospital. J. Clin. Psychiatry 68 (2007) 1574-1583
31. Heffernan K., Cloitre M., Tardiff K., Marzuk P.M., Portera L., and Leon A.C. Childhood trauma as a correlate of lifetime opiate use in psychiatric patients. Addict. Behav. 25 (2000) 797-803
32. Hellings J.A., and Warnock J.K. Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacol. Bull. 30 (1994) 245-250
33. Herman J.L. Complex PTSD: a syndrome in survivors of prolonged and repeated trauma. J. Trauma. Stress 5 (1992) 377-391
34. Insel T.R., Kinsley C.H., Mann P.E., and Bridges R.S. Prenatal stress has long-term effects on brain opiate receptors. Brain Res. 511 1 (1990) 93-97
35. Isometsa E.T., Henriksson M.M., Heikkinen M.E., Aro H.M., Marttunen M.J., Kuoppasalmi K.I., and Lonnqvist J.K. Suicide among subjects with personality disorders. Am. J. Psychiatry 153 (1996) 667-673
36. Joyce P.R., McKenzie J.M., Mulder R.T., Luty S.E., Sullivan P.F., Miller A.L., and Kennedy M.A. Genetic, developmental and personality correlates of self-mutilation in depressed patients. Aust. N. Z. J. Psychiatry 40 (2006) 225-229
37. Kalin N.H., Shelton S.E., and Barksdale C.M. Behavioral and physiologic effects of CRH administered to infant primates undergoing maternal separation. Neuropsychopharmacology 2 (1989) 97-104
38. Kemperman I. Pain assessment in self-injurious patients with borderline personality disorder using signal detection theory. Psychiatry Res. 70 (1997) 175-183
39. Kemperman I., Russ M.J., and Shearin E. Self-injurious behavior and mood regulation in borderline patients. J. Pers. Disord. 11 (1997) 146-157
40. Kishore S., and Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 5758 (2006) 230-232
41. Klonsky D. The functions of deliberate self-injury: a review of the evidence. Clin. Psychol. Rev. 27 (2007) 226-239
42. Lai J., Luo M.C., Chen Q., Ma S., Gardell L.R., Ossipov M.H., and Porreca F. Dynorphin A activates bradykinin receptors to maintain neuropathic pain. Nat. Neurosci. 9 (2006) 1534-1540
43. Langbehn D.R., and Pfohl B. Clinical correlates of self-mutilation among psychiatric inpatients. Ann. Clin. Psychiatry 5 (1993) 45-51
44. Lesem M.D., Berrettini W.H., Kaye W.H., and Jimerson D.C. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biol. Psychiatry 29 (1991) 244-252
45. Ludascher P., Bohus M., Lieb K., Philipsen A., and Jochims A. Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Res. 149 (2007) 291-296
46. Mann J.J., and Currier D. A review of prospective studies of biological predictors of suicidal behavior in mood disorders. Arch. Suicide Res. 11 (2007) 3-16
47. McGee M.D. Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone. J. Clin. Psychiatry 58 (1997) 32-33
48. Meyendorff E., Jain A., Träskman-Bendz L., Stanley B., and Stanley M. The effects of fenfluramine on suicidal behavior. Psychopharmacol. Bull. 22 (1986) 155-159
49. Nada-Raja S., Skegg K., Langley J., Morrison D., and Sowerby P. Self-harming behaviors in a population-based sample of young adults. Suicide Life Threat. Behav. 34 (2004) 177-186
50. Nagamitsu S. CSF β-endorphin levels in pediatric neurologic disorders. Kurume Med. J. 40 (1993) 233-241
51. Nagamitsu S., Matsuishi T., Kisa T., Komori H., Miyazaki M., Hashimoto T., Yamashita Y., Ohtaki E., and Kato H. CSF β-endorphin levels in patients with infantile autism. J. Autism Dev. Disord. 27 (1997) 155-163
52. Nakao K., Oki S., Tanaka I., Horii K., Nakai Y., Furui T., Fukushima M., Kuwayama A., Kageyama N., and Imura H. Immunoreactive β-endorphin and adrenocorticotropin in human cerebrospinal fluid. J. Clin. Invest. 66 (1980) 1383-1390
53. Nock M., and Favazza A. Nonsuicidal self-injury: definition and classification. In: Nock M. (Ed). Understanding Nonsuicidal Self-injury (2007), American Psychological Association, Washington, D.C 9-36
54. Nock M., Joiner T., Gordon K., Lloyd-Richardson E., and Prinstein M. Non-suicidal self-injury among adolescents: diagnostic correlates and relation to suicide attempts. Psychiatry Res. 144 (2006) 65-72
55. Overall J.E., and Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 10 (1962) 799-812
56. Paul T., Schroeter K., Dahme B., and Nutzinger D.O. Self-injurious behavior in women with eating disorders. Am. J. Psychiatry 159 (2002) 408-411
57. Perry C.J., Fowler J.C., Bailey A., Clemence A.J., Plakun E.M., Zheutlin B., and Speanburg S. Improvement and recovery from suicidal and self-destructive phenomena in treatment-refractory disorders. J. Nerv. Ment. Dis. 197 (2009) 28-34
58. Pike J.L., Smith T.L., Hauger R.L., Nicassio P.M., Patterson T.L., McClintock J., Costlow C., and Irwin M.R. Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom. Med. 59 (1997) 447-457
59. Powers S.I., and McArdle E.T. Coping strategies moderate the relation of hypothalamus-pituitary-adrenal axis reactivity to self-injurious behavior. Ann. N. Y. Acad. Sci. 1008 (2003) 285-288
60. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429 (2001) 79-91
61. Quirarte G.L., Galvez R., Roozendaal B., and McGaugh J.L. Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 808 (1998) 134-140
62. Roggenbach J., Müller-Oerlinghausen B., and Franke L. Suicidality, impulsivity and aggression: Is there a link to 5HIAA concentration in the cerebrospinal fluid?. Psychiatry Res. 113 1-2 (2002) 193-206
63. Rubinstein M., Mogil J.S., Japon M., Chan E.C., Allen R.G., and Low M.J. Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis. Proc. Natl. Acad. Sci. 93 (1996) 3395-4000
64. Samuelsson H., Ekman R., and Hedner T. CSF neuropeptides in cancer pain: effects of spinal opioid therapy. Acta Anaesthesiol. Scand. 37 (1993) 502-508
65. Sanchez M.D., Milanes M.V., Fuente T., and Laorden M.L. Prenatal stress alters the hypothalamic levels of methionine-enkephalin in pup rats. Neuropeptides 23 (1992) 131-135
66. Sanchez M.D., Milanes M.V., Pazos A., Diaz A., and Laorden M.L. Autoradiographic evidence of mu-opioid receptors down-regulation after prenatal stress in offspring rat brain. Brain Res. Dev. Brain Res. 94 (1996) 14-21
67. Sanchez M.D., Milanes M.V., Pazos A., Diaz A., and Laorden M.L. Autoradiographic evidence of delta-opioid receptor downregulation after prenatal stress in offspring rat brain. Pharmacology 60 (2000) 13-18
68. Sandman C.A. Efficacy of opioid antagonists in attenuating self-injurious behavior. In: Dean R., Bilsky E.J., and Negus S.S. (Eds). Opiate Receptors and Antagonists from Bench to Clinic (2009), New York, Humana Press
69. Sandman C.A., Datta P.C., Barron J., Hoehler F.K., Williams C., and Swanson J.M. Naloxone attenuates self-abusive behavior in developmentally disabled clients. Appl. Res. Ment. Retard. 4 (1983) 5-11
70. Sarrias M.J., Cabre P., Martinez E., and Artigas F. Relationship between serotonergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. J. Neurochem. 54 3 (1990) 783-786
71. Saxe G.N., Chawla N., and Van der Kolk B. Self-destructive behavior in patients with dissociative disorders. Suicide Life Threat. Behav. 32 (2002) 313-320
72. Schmahl C., Greffrath W., Baumgärtner U., Schlereth T., Magerl W., Philipsen A., Lieb K., Bohus M., and Treede R. Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings. Pain 110 (2004) 470-479
73. Sher L. The endogenous euphoric reward system that reinforces physical training: a mechanism for mankind's survival. Med. Hypotheses 51 (1998) 449-450
74. Simeon D., and Hollander E. Self Injurious Behaviors: Assessment and Treatment (2001), American Psychiatric Publishing, Inc., Washington, DC
75. Simeon D., Stanley B., Frances A., Mann J.J., Winchel R., and Stanley M. Self-mutilation in personality disorders: psychological and biological correlates. Am. J. Psychiatry 149 2 (1992) 221-226
76. Stanley B., and Brodsky B. Suicidal and self-injurious behavior in borderline personality disorder: the self-regulation action model. In: Gunderson J., and Hoffman P. (Eds). Borderline Personality Disorder Perspectives: From Professional to Family Member, Sharing Knowledge, Building Partnerships (2005), American Psychiatric Press, Washington, DC
77. Stanley B., and Siever L. The interpersonal dimension of borderline personality disorder: towards a neuropeptide model. Am. J. Psychiatry 167 (2010) 24-39
78. Stanley B., Winchel R., Molcho A., Simeon D., and Stanley M. Suicide and the self-harm continuum: phenomenological and biochemical evidence. Int. Rev. Psychiatry 4 (1992) 149-155
79. Stevens C.W., and Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J. Pharmacol. Exp. Ther. 238 (1986) 833-838
80. Thompson T., Hackenberg T., Cerutti D., Baker D., and Axtell S. Opioid antagonist effects on self-injury in adults with mental retardation: response form and location as determinants of medication effects. Am. J. Ment. Retard. 99 (1994) 85-102
81. Tsigos C., Crosby S.R., Gibson S., Young R.J., and White A. Proopiomelanocortin is the predominant adrenocorticotropin-related peptide in human cerebrospinal fluid. J. Clin. Endocrinol. Metab. 76 (1993) 620-624
82. Urban M., and Gebhart G. Central mechanisms in pain. Med. Clin. North Am. 83 (1999) 585-596
83. van Goozen S.H., van den Ban E., Matthys W., Cohen-Kettenis P.T., Thijssen J.H., and van Engeland H. Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls. J. Am. Acad. Child Adolesc. Psych. 39 (2000) 1446-1451
84. van Heeringen K. The neurobiology of suicide and suicidality. Can. J. Psychiatry 48 (2003) 292-300
85. Vanderah T.W., Gardell L.R., Burgess S.E., Ibrahim M., Dogrul A., Zhong C.M., Zhang E.T., Malan T.P., Ossipov M.H., Lai J., and Porreca F. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J. Neurosci. 20 (2000) 7074-7079
86. Weizman R., Gil-Ad I., Dick J., Tyano S., Szekely G.A., and Lavon Z. Low plasma immunoreactive β-endorphin levels in autism. J. Am. Acad. Child Adolesc. Psych. 27 (1988) 430-433
87. Williams F., and Hasking P. Emotion regulation, coping and alcohol use as moderators in the relationship between non-suicidal self injury and psychological distress. Prev. Sci. Aug. 11 1 (2009) 33-41
88. Williams K.L., Ko M.C., Rice K.C., and Woods J.H. Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys. Psychoneuroendocrinology 28 (2003) 513-528
89. Wong D.F., Harris J.C., Naidu S., Yokoi F., Marenco S., Dannals R.F., Ravert H.T., Yasters M., Evans A., Rousset O., Bryan R.N., Gjedde A., Kuhar M.J., and Breese G.R. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc. Natl. Acad. Sci. 93 (1996) 5539-5543
90. Yamada K., and Nabeshima T. Stress-induced behavioral responses and multiple opioid systems in the brain. Behav. Brain Res. 67 (1995) 133-145
91. Zanarini M.C., Yong L., Frankenburg F.R., Hennen J., Reich D.B., Marino M.F., and Vujanovic A.A. Severity of reported childhood sexual abuse and its relationship to severity of borderline psychopathology and psychosocial impairment among borderline inpatients. J. Nerv. Ment. Dis. 190 (2002) 381-387
92. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., and Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315
93. Zubieta J.K., Ketter T.A., Bueller J.A., Xu Y., Kilbourn M.R., Young E.A., and Koeppe R.A. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch. Gen. Psychiatry 60 (2003) 1145-1153